Skip to main content
. 2023 Oct 26;42(1):13–18. doi: 10.1200/JCO.23.01177

FIG A2.

FIG A2.

PFS and OS for stage II and for patients with stage III-IV disease. Seven-year PFS for stage II 84.7% (95% CI, 81.0 to 87.7) and III/IV 73.4% (95% CI, 69.7 to 76.8). Seven-year OS for stage II 95.6% (95% CI, 93.2 to 97.2) and III/IV 88.7% (95% CI, 85.7 to 91.0). OS, overall survival; PFS, progression-free survival.